With a sturdy medical-phase pipeline, Agenus harnesses a combination of proprietary antibody platforms, like Retrocyte Display™ and SECANT®, and ground breaking cell therapy ways, positioning alone as a essential contributor during the biotechnology and immunotherapy arena. Maintaining